ByarD.P., SimonR.M., FriedewaldW.T., SchlesselmanJ.J., de MetsD.L., EllenbergJ.H., GailM.H., & WareJ.H. (1976) New England Journal of Medicine295, 74–80
6.
CottonT. (1963) Journal of the American Statistical Association58, 388–400
7.
GrossF. (1980) Directions and Implications of Drug Legislation and Regulation in Europe. Centre for the Study of Drug Development, Publication Series PS8035, University of Rochester Medical Centre, New York
8.
HillA.B. (1959) In: Proceedings of Council for International Organizations of Medical Sciences Conference, Vienna.Blackwell, Oxford; pp 3–7
9.
HillA.B. (1963a) British Medical Journali, 1043–1049
10.
HillA.B. (1963b) Practitioner190, 85–90
11.
Lancet (1979) i, 534–535
12.
LellouchJ., & SchwartzD. (1971) Revue de l'Institut international de statistique39, 127–136
13.
LindleyD.V. (1965) Introduction to Probability and Statistics from a Bayesian Viewpoint, part 1: Probability.Cambridge University Press, London; pp 1–2
14.
MeierP. (1975) Biometrics31, 511–529
15.
PocockS.J. (1976) Journal of Chronic Diseases29, 175–188
16.
ShawL.W., & ChalmersT.C. (1970) Annals of the New York Academy of Sciences169, 487–495
17.
SimmonsB. (1978) Journal of Medical Ethics4, 172–181
18.
SimonR. (1977) Biometrics33, 743–749
19.
WittsL.J. (1959) In: Proceedings of Council for International Organizations of Medical Sciences Conference, Vienna.Blackwell, Oxford: pp 12–13
20.
ZelenM. (1969) Journal of the American Statistical Association64, 131–146